Improvement of lymphangioleiomyomatosis following successful tofacitinib treatment for refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome

Detalles Bibliográficos
Autores principales: Liu, Shuang, Li, Chen, Tang, Ming-Wei, Xu, Wen-Shuai, Chen, Ke-Qi, Sui, Xin, Tian, Xin-Lun, Xu, Kai-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819034/
https://www.ncbi.nlm.nih.gov/pubmed/31503058
http://dx.doi.org/10.1097/CM9.0000000000000441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819034/
https://www.ncbi.nlm.nih.gov/pubmed/31503058
http://dx.doi.org/10.1097/CM9.0000000000000441

Ejemplares similares